Crit Rev Immunol. 2007;27(4):291-302.
Alpha-cobratoxin as a possible therapy for multiple sclerosis: a review of the literature leading to its development for this application.
Source
ReceptoPharm Inc., Plantation, FL 33313, USA. [email protected]
Abstract
The use of snake venom in the treatment of multiple sclerosis has been, at best, controversial. The anecdotal reports for snake venom’s beneficial effects in this condition may be supportable now by recent scientific evidence.
Cobratoxin, a neurotoxin obtained from the venom of the Thailand cobra, has demonstrated several pharmacological activities that strongly support its use in this application. By employing a chemical detoxification step, the neurotoxin can be rendered safe for administration to humans with minimal side effects.
This modified neurotoxin has demonstrated neuromodulatory, antiviral, and analgesic activity, elements associated with the multiple sclerosis condition. Modified cobratoxin has demonstrated potent immunosuppressive activity in acute and chronic animal models of the disease.
The drug is under investigation for use in adrenomyeloneuropathy and clinical trials in Multiple sclerosis are planned.
- PMID:
- 18197810
- [PubMed – indexed for MEDLINE]
Publication Types, MeSH Terms, Substances
SOURCE to this posting: NCBI PUBMED
..
If you would like, you can comment to our blog posts
LIKE this Blog by clicking the LIKE button – top left
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org to register
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
